Helen Caldwell Division of Pathology University of Edinburgh Biography Publications Institution JoVE Articles Helen Caldwell has not added a biography. If you are Helen Caldwell and would like to personalize this page please email our Author Liaison for assistance. Publications Targeting Di Rac GTPases Blocchi La Diffusione Del Cancro Al Seno Umano Intatto Oncotarget. Jun, 2012 | Pubmed ID: 22689141 Un Modello in Vitro Che Ricapitola Epiteliali Di Transizione Mesenchimale (EMT) Nel Cancro Al Seno Umano PloS One. 2011 | Pubmed ID: 21347235 Allylation Veloce Rutenio-catalizzata Di Tioli Usando Alcool Allilico Come Substrati Chemistry (Weinheim an Der Bergstrasse, Germany). Jun, 2009 | Pubmed ID: 19466722 Analisi Di Microarray Dell'espressione Di Gene Di Epatociti Mouse Di Ploidia Differente Mammalian Genome : Official Journal of the International Mammalian Genome Society. Sep, 2007 | Pubmed ID: 17726633 TNF-alfa Indotta Da Danni Al DNA in Epatociti Primari Murini International Journal of Molecular Medicine. Dec, 2003 | Pubmed ID: 14612962 L'uso di matrici inverse proteina di fase (RPPA) per esplorare Espressione Variazione proteine all'interno dei singoli tumori a cellule renali Fiach C. O'Mahony1, Jyoti Nanda1, Alexander Laird1, Peter Mullen2, Helen Caldwell3, Ian M. Overton4, Lel Eory4, Marie O'Donnell1,5, Dana Faratian6, Thomas Powles7, David J. Harrison1,2, Grant D. Stewart1 1Edinburgh Urological Cancer Group, University of Edinburgh, 2School of Medicine, University of St Andrews, 3Division of Pathology, University of Edinburgh, 4MRC Human Genetics Unit, MRC IGMM, University of Edinburgh, 5Department of Pathology, Western General Hospital, 6Breakthrough Breast Cancer Research Unit, University of Edinburgh, 7St Bartholomew's Cancer Institute, Experimental Cancer Medicine Centre, Queen Mary University of London JoVE 50221 Medicina
L'uso di matrici inverse proteina di fase (RPPA) per esplorare Espressione Variazione proteine all'interno dei singoli tumori a cellule renali Fiach C. O'Mahony1, Jyoti Nanda1, Alexander Laird1, Peter Mullen2, Helen Caldwell3, Ian M. Overton4, Lel Eory4, Marie O'Donnell1,5, Dana Faratian6, Thomas Powles7, David J. Harrison1,2, Grant D. Stewart1 1Edinburgh Urological Cancer Group, University of Edinburgh, 2School of Medicine, University of St Andrews, 3Division of Pathology, University of Edinburgh, 4MRC Human Genetics Unit, MRC IGMM, University of Edinburgh, 5Department of Pathology, Western General Hospital, 6Breakthrough Breast Cancer Research Unit, University of Edinburgh, 7St Bartholomew's Cancer Institute, Experimental Cancer Medicine Centre, Queen Mary University of London JoVE 50221 Medicina